Altered TGF-β signaling in fetal fibroblasts: What is known about the underlying mechanisms?

Wound Repair and Regeneration

Volumn 22, Issue 1, 2014, Pages 3-13

  Walraven, Mariëlle ^a,b   Gouverneur, Mirella ^a,b   Middelkoop, Esther ^a,b   Beelen, Rob H J ^a   Ulrich, Magda M W ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Association of Dutch Burn Centers   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOCYTOSIS; EXTRACELLULAR MATRIX; FETUS CELL; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; KERATINOCYTE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SKIN FIBROSIS; UPREGULATION; WOUND HEALING;

ADULT; CELL COMMUNICATION; CELLS, CULTURED; CICATRIX; COLLAGEN; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; FIBROBLASTS; HUMANS; MALE; SIGNAL TRANSDUCTION; SKIN; SKIN PHYSIOLOGICAL PHENOMENA; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84891835741     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12098     Document Type: Review

References (100)

1. Klass BR, Grobbelaar AO, Rolfe KJ,. Transforming growth factor β signalling, wound healing and repair: a multifunctional cytokine with clinical implications for wound repair, a delicate balance. Postgrad Med J 2009; 85: 9-14.
2. Bayat A, McGrouther DA, Ferguson MWJ,. Skin scarring. BMJ 2003; 326: 88-92.
3. Bloemen MCT, van der Veer WM, Ulrich MMW, Van Zuijlen PPM, Niessen FB, Middelkoop E,. Prevention and curative management of hypertrophic scar formation. Burns 2009; 35: 463-475.
4. Bock O, Schmid-Ott G, Malewski P, Mrowietz U,. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 2006; 297: 433-438.
5. Xie B, Xiao SC, Zhu SH, Xia ZF,. Evaluation of long term health-related quality of life in extensive burns: a 12-year experience in a burn center. Burns 2011; 38: 348-355.
6. van Loey NE, van Beeck EF, Faber BW, van de Schoot R, Bremer M,. Health-related quality of life after burns: a prospective multicenter cohort study with 18 months follow-up. J Trauma Acute Care Surg 2012; 72: 513-520.
7. Ferguson MW, Whitby DJ, Shah M, Armstrong J, Siebert JW, Longaker MT,. Scar formation: the spectral nature of fetal and adult wound repair. Plast Reconstr Surg 1996; 97: 854-860.
8. Satish L, Kathju S,. Cellular and molecular characteristics of scarless versus fibrotic wound healing. Dermatol Res Pract 2010; 2010: 790234.
9. Longaker MT, Whitby DJ, Ferguson MW, Lorenz HP, Harrison MR, Adzick NS,. Adult skin wounds in the fetal environment heal with scar formation. Ann Surg 1994; 219: 65-72.
10. Rowlatt U,. Intrauterine wound healing in a 20 week human fetus. Virchows Archiv 1979; 381: 353-361.
11. Lorenz HP, Whitby DJ, Longaker MT, Adzick NS,. Fetal wound healing: the ontogeny of scar formation in the non-human primate. Ann Surg 1993; 217: 391-396.
12. Bullard KM, Longaker MT, Lorenz HP,. Fetal wound healing: current biology. World J Surg 2003; 27: 54-61.
13. Lorenz HP, Lin RY, Longaker MT, Whitby DJ, Adzick NS,. The fetal fibroblast: the effector cell of scarless fetal skin repair. Plast Reconstr Surg 1995; 96: 1251-1259.
14. Knight KR, Lepore DA, Horne RS, Ritz M, Hurley JV, Kumta S, et al. Collagen content of uninjured skin and scar tissue in foetal and adult sheep. Int J Exp Pathol 1993; 74: 583-591.
15. Merkel JR, DiPaolo BR, Hallock GG, Rice DC,. Type I and type III collagen content of healing wounds in fetal and adult rats. Proc Soc Exp Biol Med 1988; 187: 493-497.
16. Smith LT, Holbrook KA, Madri JA,. Collagen types I, III, and V in human embryonic and fetal skin. Am J Anat 1986; 175: 507-521.
17. Coolen N, Schouten K, Middelkoop E, Ulrich M,. Comparison between human fetal and adult skin. Arch Dermatol Res 2010; 302: 47-55.
18. Larson BJ, Longaker MT, Lorenz HP,. Scarless fetal wound healing: a basic science review. Plast Reconstr Surg 2010; 126: 1172-1180.
19. Knight KR, Horne RS, Lepore DA, Kumta S, Ritz M, Hurley JV, et al. Glycosaminoglycan composition of uninjured skin and of scar tissue in fetal, newborn and adult sheep. Res Exp Med (Berl) 1994; 194: 119-127.
20. Whitby DJ, Ferguson MW,. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 1991; 112: 651-668.
21. Rozario T, DeSimone DW,. The extracellular matrix in development and morphogenesis: a dynamic view. Dev Biol 2010; 341: 126-140.
22. Eckes B, Kessler D, Aumailley M, Krieg T,. Interactions of fibroblasts with the extracellular matrix: implications for the understanding of fibrosis. Springer Semin Immunopathol 2000; 21: 415-429.
23. Wilgus TA,. Regenerative healing in fetal skin: a review of the literature. Ostomy Wound Manage 2007; 53: 16-31.
24. Cowin AJ, Brosnan MP, Holmes TM, Ferguson MW,. Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse. Dev Dyn 1998; 212: 385-393.
25. Lin RY, Sullivan KM, Argenta PA, Peter Lorenz H, Scott Adzick N,. Scarless human fetal skin repair is intrinsic to the fetal fibroblast and occurs in the absence of an inflammatory response. Wound Repair Regen 1994; 2: 297-305.
26. Nussbaum C, Sperandio M,. Innate immune cell recruitment in the fetus and neonate. J Reprod Immunol 2011; 90: 74-81.
27. Levy O,. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-390.
28. Adolph VR, DiSanto SK, Bleacher JC, Dillon PW, Krummel TM,. The potential role of the lymphocyte in fetal wound healing. J Pediatr Surg 1993; 28: 1316-1320.
29. Longaker MT, Bouhana KS, Harrison MR, Danielpour D, Roberts AB, Banda MJ,. Wound healing in the fetus: possible role for inflammatory macrophages and transforming growth factor-beta isoforms. Wound Repair Regen 1994; 2: 104-112.
30. Olutoye OO, Alaish SM, Carr ME, Jr, Paik M, Yager DR, Cohen IK, et al. Aggregatory characteristics and expression of the collagen adhesion receptor in fetal porcine platelets. J Pediatr Surg 1995; 30: 1649-1653.
31. Whitby DJ, Ferguson MW,. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991; 147: 207-215.
32. Dang CM, Beanes SR, Soo C, Ting K, Benhaim P, Hedrick MH, et al. Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast Reconstr Surg 2003; 111: 1969-1979.
33. Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA,. Regulation of scar formation by vascular endothelial growth factor. Lab Invest 2008; 88: 579-590.
34. Colwell AS, Beanes SR, Soo C, Dang C, Ting K, Longaker MT, et al. Increased angiogenesis and expression of vascular endothelial growth factor during scarless repair. Plast Reconstr Surg 2005; 115: 204-212.
35. Namazi MR, Fallahzadeh MK, Schwartz RA,. Strategies for prevention of scars: what can we learn from fetal skin ? Int J Dermatol 2011; 50: 85-93.
36. Hsu M, Peled ZM, Chin GS, Liu W, Longaker MT,. Ontogeny of expression of transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 3, and TGF-beta receptors I and II in fetal rat fibroblasts and skin. Plast Reconstr Surg 2001; 107: 1787-1794.
37. Chen W, Fu X, Ge S, Sun T, Zhou G, Jiang D, et al. Ontogeny of expression of transforming growth factor-β and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair Regen 2005; 13: 68-75.
38. Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, et al. Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome. Gene Ther 2003; 10: 59-71.
39. Shah M, Foreman DM, Ferguson MW,. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995; 108: 985-1002.
40. McCollum PT, Bush JA, James G, Mason T, O'Kane S, McCollum C, et al. Randomized phase II clinical trial of avotermin versus placebo for scar improvement. Br J Surg 2011; 98: 925-934.
41. Ferguson MW, Duncan J, Bond J, Bush J, Durani P, So K, et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies. Lancet 2011; 373: 1264-1274.
42. Santibanez JF, Quintanilla M, Bernabeu C,. TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2011; 121: 233-251.
43. Diegelmann RF, Evans MC,. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9: 283-289.
44. Wipff PJ, Rifkin DB, Meister JJ, Hinz B,. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007; 179: 1311-1323.
45. Annes JP, Munger JS, Rifkin DB,. Making sense of latent TGFβ activation. J Cell Sci 2003; 116: 217-224.
46. Todorovic V, Jurukovski V, Chen Y, Fontana L, Dabovic B, Rifkin DB,. Latent TGF-β binding proteins. Int J Biochem Cell Biol 2005; 37: 38-41.
47. Lyons RM, Keski-Oja J, Moses HL,. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol 1988; 106: 1659-1665.
48. Bascom CC, Wolfshohl JR, Coffey RJ, Madisen L, Webb NR, Purchio AR, et al. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol Cell Biol 1989; 9: 5508-5515.
49. Govinden R, Bhoola KD,. Genealogy, expression, and cellular function of transforming growth factor-β. Pharmacol Ther 2003; 98: 257-265.
50. Roberts AB, Sporn MB,. Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol Reprod Dev 1992; 32: 91-98.
51. Cartney-Francis NL, Wahl SM,. Transforming growth factor beta: a matter of life and death. J Leukoc Biol 1994; 55: 401-409.
52. Ferguson MWJ, O'Kane S,. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-850.
53. Yoshimura A, Wakabayashi Y, Mori T,. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 2010; 147: 781-792.
54. Rolfe KJ, Grobbelaar AO,. The growth receptors and their role in wound healing. Curr Opin Investig Drugs 2010; 11: 1221-1228.
55. Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, et al. Recombinant human anti-transforming growth factor β1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 2007; 56: 323-333.
56. Wu L, Siddiqui A, Morris DE, Cox DA, Roth SI, Mustoe TA,. Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence: histologic and competitive reverse-transcription-polymerase chain reaction Studies. Arch Surg 1997; 132: 753-760.
57. Rhett JM, Ghatnekar GS, Palatinus JA, O'Quinn M, Yost MJ, Gourdie RG,. Novel therapies for scar reduction and regenerative healing of skin wounds. Trends Biotechnol 2008; 26: 173-180.
58. van der Slot AJ, van Dura EA, de Wit EC, De GJ, Huizinga TW, Bank RA, et al. Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels. Biochim Biophys Acta 2005; 1741: 95-102.
59. Ulrich MMW, Verkerk M, Reijnen L, Vlig M, van den Bogaerdt AJ, Middelkoop E,. Expression profile of proteins involved in scar formation in the healing process of full-thickness excisional wounds in the porcine model. Wound Repair Regen 2007; 15: 482-490.
60. Inman GJ, Nicolas FJ, Hill CS,. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity. Mol Cell 2002; 10: 283-294.
61. Derynck R, Zhang YE,. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003; 425: 577-584.
62. Leask A, Abraham DJ,. TGF-β signaling and the fibrotic response. FASEB J 2004; 18: 816-827.
63. Vilchis-Landeros MM, Montiel JL, Mendoza V, Mendoza-Hernandez G, Lopez-Casillas F,. Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent. Biochem J 2001; 355: 215-222.
64. McLean S, Di Guglielmo GM,. TGFβ (transforming growth factor β) receptor type-III directs clathrin-mediated endocytosis of TGFβ receptor types-I and II. Biochem J 2010; 429: 137-145.
65. Javelaud D, Mauviel A,. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene 2005; 24: 5742-5750.
66. Le Roy C, Wrana JL,. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005; 6: 112-126.
67. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL,. Distinct endocytic pathways regulate TGF-β receptor signalling and turnover. Nat Cell Biol 2003; 5: 410-421.
68. Zhang XL, Topley N, Ito T, Phillips A,. Interleukin-6 regulation of transforming growth factor (TGF)-β receptor compartmentalization and turnover enhances TGF-β1 signaling. J Biol Chem 2005; 280: 12239-12245.
69. Kikuchi A, Yamamoto H, Sato A, Matsumoto S,. New insights into the mechanism of Wnt signaling pathway activation. Int Rev Cell Mol Biol 2011; 291: 21-71.
70. Willnow TE, Christ A, Hammes A,. Endocytic receptor-mediated control of morphogen signaling. Development 2012; 139: 4311-4319.
71. Lee EK, Lee YS, Han IO, Park SH,. Expression of caveolin-1 reduces cellular responses to TGF-β1 through down-regulating the expression of TGF-β type II receptor gene in NIH3T3 fibroblast cells. Biochem Biophys Res Commun 2007; 359: 385-390.
72. Kim S, Lee Y, Seo JE, Cho KH, Chung JH,. Caveolin-1 increases basal and TGF-β1-induced expression of type I procollagen through PI-3 kinase/Akt/mTOR pathway in human dermal fibroblasts. Cell Signal 2008; 20: 1313-1319.
73. Le Saux CJ, Teeters K, Miyasato SK, Hoffmann PR, Bollt O, Douet V, et al. Down-regulation of caveolin-1, an inhibitor of transforming growth factor-beta signaling, in acute allergen-induced airway remodeling. J Biol Chem 2008; 283: 5760-5768.
74. Zou H, Stoppani E, Volonte D, Galbiati F,. Caveolin-1, cellular senescence and age-related diseases. Mech Ageing Dev 2011; 132 (11-12): 533-542.
75. Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 1998; 17: 6633-6648.
76. Zhang GY, He B, Liao T, Luan Q, Tao C, Nie CL, et al. Caveolin 1 inhibits transforming growth factor-β1 activity via inhibition of Smad signaling by hypertrophic scar derived fibroblasts in vitro. J Dermatol Sci 2011; 62: 128-131.
77. Zhang GY, Yu Q, Cheng T, Liao T, Nie CL, Wang AY, et al. Role of caveolin-1 in the pathogenesis of tissue fibrosis by keloid-derived fibroblasts in vitro. Br J Dermatol 2011; 164: 623-627.
78. Pratsinis H, Giannouli CC, Zervolea I, Psarras S, Stathakos D, Kletsas D,. Differential proliferative response of fetal and adult human skin fibroblasts to transforming growth factor-β. Wound Repair Regen 2004; 12: 374-383.
79. Giannouli CC, Kletsas D,. TGF-β regulates differentially the proliferation of fetal and adult human skin fibroblasts via the activation of PKA and the autocrine action of FGF-2. Cell Signal 2006; 18: 1417-1429.
80. Carre AL, James AW, MacLeod L, Kong W, Kawai K, Longaker MT, et al. Interaction of Wingless protein (Wnt), transforming growth factor-β, and hyaluronan production in fetal and postnatal fibroblasts. Plast Reconstr Surg 2010; 125: 74-88.
81. Rolfe KJ, Richardson J, Vigor C, Irvine LM, Grobbelaar AO, Linge C,. A role for TGF-β1-induced cellular responses during wound healing of the non-scarring early human fetus? J Invest Dermatol 2007; 127: 2656-2667.
82. Moulin V, Tam BY, Castilloux G, Auger FA, O'Connor-McCourt MD, Philip A, et al. Fetal and adult human skin fibroblasts display intrinsic differences in contractile capacity. J Cell Physiol 2001; 188: 211-222.
83. Soo C, Beanes SR, Hu FY, Zhang X, Dang C, Chang G, et al. Ontogenetic transition in fetal wound transforming growth factor-β regulation correlates with collagen organization. Am J Pathol 2003; 163: 2459-2476.
84. Cowin AJ, Holmes TM, Brosnan P, Ferguson MW,. Expression of TGF-beta and its receptors in murine fetal and adult dermal wounds. Eur J Dermatol 2001; 11: 424-431.
85. Rolfe KJ, Irvine LM, Grobbelaar AO, Linge C,. Differential gene expression in response to transforming growth factor-β1 by fetal and postnatal dermal fibroblasts. Wound Repair Regen 2007; 15: 897-906.
86. Sullivan KM, Lorenz HP, Meuli M, Lin RY, Adzick NS,. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg 1995; 30: 198-202.
87. Nath RK, LaRegina M, Markham H, Ksander GA, Weeks PM,. The expression of transforming growth factor type beta in fetal and adult rabbit skin wounds. J Pediatr Surg 1994; 29: 416-421.
88. Goldberg SR, McKinstry RP, Sykes V, Lanning DA,. Rapid closure of midgestational excisional wounds in a fetal mouse model is associated with altered transforming growth factor-β isoform and receptor expression. J Pediatr Surg 2007; 42: 966-973.
89. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, et al. Differential expression of fibromodulin, a transforming growth factor-β modulator, in fetal skin development and scarless repair. Am J Pathol 2000; 157: 423-433.
90. Gosiewska A, Yi CF, Brown LJ, Cullen B, Silcock D, Geesin JC,. Differential expression and regulation of extracellular matrix-associated genes in fetal and neonatal fibroblasts. Wound Repair Regen 2001; 9: 213-222.
91. Werner S, Krieg T, Smola H,. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007; 127: 998-1008.
92. Colwell AS, Faudoa R, Krummel TM, Longaker MT, Lorenz HP,. Transforming growth factor-β, Smad, and collagen expression patterns in fetal and adult keratinocytes. Plast Reconstr Surg 2007; 119: 852-857.
93. Colwell AS, Yun R, Krummel TM, Longaker MT, Lorenz HP,. Keratinocytes modulate fetal and postnatal fibroblast transforming growth factor-beta and Smad expression in co-culture. Plast Reconstr Surg 2007; 119: 1440-1445.
94. Colwell AS, Krummel TM, Longaker MT, Lorenz HP,. Fetal and adult fibroblasts have similar TGF-beta-mediated, Smad-dependent signaling pathways. Plast Reconstr Surg 2006; 117: 2277-2283.
95. Glim JE, Niessen FB, Everts V, van Egmond M, Beelen RHJ,. Platelet derived growth factor-CC secreted by M2 macrophages induces alpha-smooth muscle actin expression by dermal and gingival fibroblasts. Immunobiology 2013; 218: 924-929.
96. Wynes MW, Frankel SK, Riches DW,. IL-4-induced macrophage-derived IGF-I protects myofibroblasts from apoptosis following growth factor withdrawal. J Leukoc Biol 2004; 76: 1019-1027.
97. Olutoye OO, Yager DR, Cohen IK, Diegelmann RF,. Lower cytokine release by fetal porcine platelets: a possible explanation for reduced inflammation after fetal wounding. J Pediatr Surg 1996; 31: 91-95.
98. Olutoye OO, Barone EJ, Yager DR, Cohen IK, Diegelmann RF,. Collagen induces cytokine release by fetal platelets: implications in scarless healing. J Pediatr Surg 1997; 32: 827-830.
99. Rae F, Woods K, Sasmono T, Campanale N, Taylor D, Ovchinnikov DA, et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol 2007; 308: 232-246.
100. Dreymueller D, Denecke B, Ludwig A, Jahnen-Dechent W,. Embryonic stem cell-derived M2-like macrophages delay cutaneous wound healing. Wound Repair Regen 2013; 21: 44-54.